Oxford University: Funding, Team & Investors | Startup Intros

Loading organizations...

Oxford University: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Nov 1, 2025	Scripta Therapeutics	$12.0M Seed	Apollo Health Ventures, Oxford Science Enterprises	AlbionVC, Parkwalk Advisors, YZR Capital
Oct 16, 2025	Wild Bioscience	$59.4M Series A	Larry Ellison	Braavos Capital, Ed Bussey
Jul 1, 2025	Ultromics	$55.0M Series C	Victor Westerlind, Alastair Stewart, Umur Hursever	HealthQuest Capital, Sandbox Industries, BlueCross BlueShield Venture Partners, Google Ventures, Oxford Science Enterprises, University of Chicago Medicine, UPMC Enterprises
Mar 6, 2024	Louisa AI	$5.0M Seed	—	Sandiip Bhammer, Evolution Ventures, Gaingels, Nucleus Capital, Palm Drive Capital
Apr 1, 2023	Caristo Diagnostics	$16.0M Series A	Heather Roxborough	Business Growth Fund, Optum Ventures, BGF, Longwall Ventures, Oxford Investment Consultants
Jul 21, 2022	Brill Power	$10.5M Series A	James Ferrier, John Bromley	Climate-KIC, Oxford Investment Consultants, Oxford Science Enterprises, Shell Ventures
Apr 1, 2022	OMass Therapeutics	$95.0M Series B	GV, Northpond Ventures, Sanofi Ventures	Forbion, Versant Ventures, Ysios Capital, Oxford Science Enterprises, Edward Hodgkin
Dec 1, 2021	Brainomix	$21.0M Series B	Parkwalk Advisors, Oliver Reuss	Boehringer Ingelheim Venture Fund, Tencent
Feb 12, 2020	Oxford VR	$12.9M Series A	Ashish Patel	GT Healthcare Capital Partners, Isabel Fox, Oxford Science Enterprises
Jul 18, 2019	Zegami	$1.6M Other Equity	Oxford Technology and Innovations, RT Capital	Oxford Science Enterprises, Adam Workman
Sep 3, 2018	Evox Therapeutics	$45.9M Series B	Redmile Group	Borealis Ventures, Cowen Healthcare Investments, Google Ventures, Oxford Science Enterprises
May 1, 2018	Orbit Discovery	$9.0M Series A	Oxford Science Enterprises	Borealis Ventures, SV Health Investors, Perivoli Innovations, RT Ventures
Apr 3, 2018	Brainomix	$9.8M Other Equity	Parkwalk Advisors	Boehringer Ingelheim, Chimera Partners
Apr 30, 2010	Oxford Immunotec	$26.0M Series D	Vijay Lathi	Clarus Ventures, Draper Esprit, Kaiser Permanente Ventures, NTEC, Jonathan Gee, The Dow Chemical Company, Wellington Partners